Current concepts on interstitial lung disease in children

Current Opinion in Pediatrics

Volumn 11, Issue 3, 1999, Pages 200-204

  Howenstine, Michelle S ^a   Eigen, Howard ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; HYDROXYCHLOROQUINE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; CELL DIFFERENTIATION; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL FEATURE; DRUG TARGETING; GAS EXCHANGE; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; INTERSTITIAL LUNG DISEASE; INTRAVENOUS DRUG ADMINISTRATION; LUNG BIOPSY; LUNG DEVELOPMENT; LUNG DISEASE; LUNG INFILTRATE; LUNG LAVAGE; MORBIDITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; THORAX RADIOGRAPHY; VIRUS INFECTION;

CHILD; HUMANS; INFLAMMATION; LUNG DISEASES, INTERSTITIAL; PEDIATRICS;

EID: 0033052874     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199906000-00004     Document Type: Short Survey

References (25)

1. 1 Fan LL, Langston C: Chronic interstitial lung disease in children. Pediatr Pulmonol 1993, 16:184-186.
2. 2 Kobayashi H, Gabazza EC, Taguchi O, Wada H, Takeya H, Nishioka J, et al.: Protein C anticoagulant system in patients with interstitial lung disease. Am J Respir Crit Care Med 1998, 157:1850-1854.
3. 3 Hilman BC: Interstitial lung disease in children. In Pediatric Respiratory Disease. Edited by Hilman BC. Philadelphia: WB Saunders; 1993:353-367.
4. 4 Fan LL: Pediatric interstitial lung disease. In Interstitial Lung Disease, edn 3. Edited by Schwarz ML, King TE, Hamilton: BC Decker; 1998:103-118. This comprehensive chapter reviews ILD with special emphasis on unique pediatric diseases.
5. 5 Raghu G, Mageto YN: Genetic predisposition of interstitial lung disease. In Interstitial Lung Disease, edn 3. Edited by Schwarz MI, King TE. BC Decker; 1998.117-134.
6. 6 Lympany PA, du Bois RM: Interstitial lung disease: basic mechanisms and genetic predisposition, Monaldi Arch Chest Dis 1997, 52:1, 33-36. This paper reviews proposals linking the immunologie response in ILD to a genetic predisposition.
7. 7 Wangoo A, Shaw RJ, Diss TC, Farrell PJ, du Bois RM, Nicholson AG: Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 1997, 52:888-891.
8. 8 Reddy A, Hermione Lyall EG, Crawford DH: Epstein-Barr virus and lymphoid interstitial pneumonitis: an association revisited. Pediatr Infect Dis J 1998, 17:82-83.
9. 9 Schroten H, Manz S, Köhler H, Wolf U, Brockmann M, Riedel F: Fatal desquamative interstitial pneumonia associated with proven CMV infection in an 8-month-old boy. Pediatr Pulmonol 1998, 25:345-347.
10. 10 Stewart CEH, Rotwen P: Growth, differentiation and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996, 76:1005-1026.
11. 11 McAnulty RJ, Guerreiro D, Cambrey AD, Laurent GJ: Growth factor activity in lung during compensatory growth after pneumonectomy-evidence of a role for IGF1. Eur Respir J 1992, 5:739-747.
12. 12 Chadelat K, Boule M, Corroyer S, Fauroux B, Delaisi B, Tournier G, Clement A: Expression of insulin like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease. Eur Respir J 1998, 11:1329-1336. This is a preview of pulmonary inflammation and the possible role of insulin-like growth factors.
13. 13 Pitzales C, Kensley G, Panayi G: Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy. Ann Rheum Dis 1994, 53:287-288.
14. 14 Southcott AM, Hemingway I, Lorimer S, Sugars K, Hellewell PG, Black CM, et al.: Adhesion molecule expression in the lung: a comparison between normal and diffuse interstitial lung disease. Eur Respir J 1998, 11:91-98.
15. 15 Dabbagh K, Chambers RC, Laurent GJ: From clot to collagen: coagulation peptides in interstitial lung disease. Eur Respir J 1998, 11:1002-1005. This paper provides a general review of the role of coagulation pathways in inflammation and possibly in lung injury.
16. 16 Fan LL, Kozinetz CA: Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 1997, 156:939-942.
17. 17 Fan LL, Kozinetz CA, Deterding RR, Brugman SM: Evaluation of a diagnostic approach to pediatric interstitial lung disease. Pediatrics 1998, 101:82-85. This paper provides suggestions and an algorithm for the evaluation of ILD done using both invasive and noninvasive techniques.
18. 18 Xaubet A, Agusti C, Luburich P, Roca J, Montón C, Ayuso MC, et al.: Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 158:431-436.
19. 19 Fan LL, Lung MCL, Wagener JS: The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates. Pediatr Pulmonol 1997, 23:8-13.
20. 20 Hilman BC: Diagnosis and treatment of ILD. Pediatr Pulmonol 1997, 23:1-7.
21. 21 Fan LL, Kozinetz CA, Wojtczak HA, Chatfield BA, Cohen AH, Rothenberg SS: Diagnostic value of transbronchial, thoracoscopic, and open lung biopsy in immunocompetent children with chronic interstitial lung disease. J Pediatr 1997, 131:565-569.
22. 22 Tobin RW, Pope CE II, Pellegrini CA, Emond MJ, Sillery J, Raghu G: Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 158:1804-1808.
23. 23 Reynolds HY: Diagnostic and management strategies for diffuse interstitial lung disease. Chest 1998, 113:192-202.
24. 24 Schnabel A, Reuter M, Gross WL: Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998, 41:1215-1220.
25. 25 Losa Garcia JE, Mateos Rodriguez F, Jimenez Lopez A, Garcia Salgado MJ, Martin de Cabo MR, Perez Losada J, Perez Arellano JL: Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir Med 1998, 92:722-728.